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(n ¼5), anterior papillary muscles of left ventricular (LV-APM) (n ¼1), septal
papillary muscles of right ventricular (RV-SPM) (n¼ 1). In ﬁve patients originating
from posterior papillary muscles of left ventricular recorded Purkinje potentials at
the target, Purkinje potentials preceded QRS complex during sinus rhythm and
immersed in QRS complex during PVC. In patients originating from LV APM and
RV SPM recorded high frequency and segment potentials preceded QRS complex
during sinus rhythm. The earliest ventricular activation was recorded 22-32
(37.313.2) ms at the site of catheter ablation. During the follow up period of 6-24
(9.864.0) months after ablation,3 patients recurred and all the patients without
complications.
Conclusions: PVC arise from the papillary muscles have featured electrocardiogram
characteristics. Catheter ablation of PAP PVC is challenging, and transthoracic
echocardiography maybe helpful for ablating PVC originating from PAP.
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Objectives: The purpose of this study was to examine the electrocardiographic (ECG)
and electrophysiological characteristics for guiding catheter ablation in patients with
two morphological types of PVC originating from the aortic sinus cusp (ASC) or great
cardiac vein(GCV).
Methods: ECG analysis was performed in 10 patients with PVC with two QRS
morphologies. During and before the procedure, the patients showed a dominated type
with LBBB and an inferior axis QRS morphology and less right bundle branch block
(RBBB) morphology were divided into group 1 and a dominated type with RBBB
QRS morphology were devided in group 2. During PVC, electroanatomical mapping
was performed in both the right ventricular outﬂow tract (RVOT) and ASC in group 1,
and only performed in ASC or GCV in group 2.
Results: All patients showed two QRS morphologies (LBBB and RBBB) during
PVC, 7 of 10 patients were in group 1, 3 of 10 patients were in group 2. During
arrhythmia, the earliest ventricular activation (EVA) was recorded 276ms (range 18-
36 ms) from the RVOT and recorded 256ms (range 18-34 ms) from the ASC in
group1, EVA was recorded 28 ms, 42 ms in ASC and 34 ms in GCV in group 2. All
patients were successfully ablated ﬁnally,7 of 10 patients originated from the left
coronary cusp ( LCC), 2 of 10 patients originated left coronary cusp- right coronary
cusp commissure (L-RCC) and 1 of 10 patient originated from GCV. All arrhythmias
were successfully abolished. None of the patients had recurrence or complications
during 18.45.1 (range 6-24 months) months of follow-up.
Conclusions: Ventricular arrhythmias originating from ACS often show two QRS
morphologies on the ECG, which may be with two breakout site and only one origin.
The origin was in LCC and L-RCC commonly, mapping in the LCC and L-RCC may
be ablated successfully. The insulated myocardial ﬁber across the ventricular outﬂow
septum may exist, and could present functional conduction. Preferential conduction
not only exist between ASC and RVOT but also exist between GVC to RVOT. Two
QRS morphologies (LBBB and RBBB) during PVC maybe another predictor of the
PVC originating from ASC or GCV.
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Objectives: Cryoballoon ablation (CBA) for atrial ﬁbrillation (AF) is wide used.
However, its outcome of long-term follow-up is still seldom reported. This study is to
investigate the long-term follow-up outcome of CBA, and further to analysis the
clinical risk factors of recurrenece.
Methods: The inpatient, operating and outpatient data of patients, who were treated
by CBA for AF in our center from January 2009 to April 2013, were retrospective
analyzed. Left atrium diameter (LAD) was measured by transthoracic echocardiog-
raphy. Failure-treatment of CBA was deﬁned by episode of AF, atrial ﬂutter, atrial
tachycardia lasted for 30 seconds after 3 months or persistent atrial arrhythmia which
needed to re-ablated during 3 months after CBA.
Results: A total of 199 patients were received 217 times CBA, and 18 patients were
received re-CBA. The incidence rates of phrenic nerve paralysis, pericardial effusion,
transient ischemic attack were 1.5% (n¼3), 0.5% (n¼1), 0.5% (n¼1), respectively. All
complications were resolved spontaneously. During a long-term follow-up of mean
2314 months, 149 patients had complete follow-up data, the treated success rate of
ﬁrst-time CBA and all CBA were 42.8% and 47.2%, respectively. The patients who
experienced the atrial arrhythmia recurrence in ﬁrst 12 month occupied 86.1% in all
failure-treated patients. The characteristics of failure-treated patients included with
more persistent AF (39.1% vs. 18.6%, P¼0.0058) and larger LAD (486 mm vs.
436 mm, P<0.0001). The Logistic analysis showed that LAD [OR¼0.896 (0.842,
0.953), P¼0.005] and age [OR¼1.037 (1.000, 1.076), P¼0.0488] could individually
predict the treat-failure after ﬁrst CBA, and only LAD [OR¼0.876 (0.822, 0.935),
P<0.0001] could individually predict the total CBA.JACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/CConclusions: CBA procedure for AF is safe and effective although the result of long-
term follow-up is preferable. Most of atrial arrhythmia are recurred during ﬁrst 12
month after CBA. LAD can individually predicted for failure-treatment of CBA.
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Objectives: A new second generation cryoballoon (G2) is design to release more
coldly temperature and to archive more rapidly pulmonary vein isolation (PVI).
However, whether its design can improve the long-term outcome of cryoablation for
patients with atrial ﬁbrillation (AF) is unknown. This study is to investigate whether
the G2 cryoballoon could improve the outcome of long-term follow-up of AF patients
by compared to a ﬁrst generation cryoballoon (G1).
Methods: The cryoablation and follow-up data of patients who were ﬁrst-time treated
for AF by a 28 mm cryoballoon from January 2012 to June 2013 in our center were
analyzed. According to the different cryoballoon used, the patients were divided to
two groups, the G1 group which treated by the ﬁrst generation cryoballoon (Arctic-
Front) and the G2 group which treated by the second generation cryoballoon (Arc-
ticFront Advance). The failure treatment of cryoablation was deﬁned as any detected
episode of AF, atrial ﬂutter, atrial tachycardia which lasted for 30 seconds after
3 months later post cryoabaltion. Left atrium diameter (LAD) was measured by
transthoracic echocardiography before cryoablation.
Results: A total of 105 patients (G1/G2 group: n¼57/48) were enrolled in this study.
The success rate of immediately PVI in the G2 group was higher than that in the G1
group [98.7 % (150/152) vs. 94.6 % (174/184), P¼0.0429]. The mean minimum
temperatures attained in the G2 group during different pulmonary vein cryoablation
were lower than that in the G1 group (P<0.01). The mean cryomapping time (30 [16,
44] min vs. 35 [25, 55]min, P<0.0001), the mean total procedure time (105 [75, 145]
min vs. 120 [80, 190]min, P¼0.0056) and the mean total X ray exposure time (17 [13,
28] min vs. 20 [13, 32] min, P¼0.0470) in the G2 group were shorter than that in the
G1 group. One patient in the G1 group occurred cardiac infusion during atrial septum
puncture. In the G2 group, two patients occurred transient phrenic nerve paralysis,
other two patients occurred transient ischemic attack, and all above patients were
recovery. During mean 13 [5, 20] months follow-up, a total of 73 patients had
complete follow-up data, and 46 (63.0%) patients were maintained sinus rhythm. The
treat-failure patients were characterized with larger LAD (487mm vs. 446mm,
P¼0.0079). The success rate of cryoablation in the G2 group was higher than that in
the G1 group [89.3% (25/28) vs. 46.7 %( 21/45), P¼0.0002], and it was been testiﬁed
by further Kaplan-Meier survival analysis regarding to different follow-up time
(Log-Rank¼5.0238, P¼0.0250). The multivariate stepwise regression showed that the
new generation cryoballoon was individually related with long-term outcome of
cryoablation [RR¼9.524 (2.511, 36.121), P¼0.0009].
Conclusions: The new generation cryoballoon ablation for AF can archived not only
with lower time of cryomapping, cryoabaltion, whole procedure and higher PVI
success rate, but also with better long-term outcome than the ﬁrst generation cry-
oabaltion. However, a higher major complication seem to occur on the beginning
stage of new generation cryoballoon application.
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Objectives: Using ILR tracing atrial ﬁbrillation patient who has been successfully
accepted standard radiofrequency ablation. To evaluate the application value of ILR in
the diagnosis and evaluation of curative effect in atrial ﬁbrillation.
Methods: Collected from May 2009 to August 2013, 25 cases of patients with
atrial ﬁbrillation, 16 males and 9 females, average 55.311.9 years old. Including
15 cases of paroxysmal atrial ﬁbrillation, persistent atrial ﬁbrillation 10cases.
14 patients choose Medtronic RevealRDX9528 ILR, 11cases choose Reveal
XTTM9529 ILR. Take outpatient follow-up, holter monitoring, electrocardiogram
and telephone inquiries and other regular or irregular follow-up methods. Record
patient clinical manifestations, the ILR provides arrhythmias discretion to adjust
the medications and other therapeutic interventions. According to the conventional
methods of the ILR implantation in patients with left parasternal anterior chest
wall. In order to better track the therapeutic efﬁcacy of radiofrequency ablation
in atrial ﬁbrillation, adopt outpatient service, local doctors to assist, telephone
inquiry mode, recording patients informations such as clinical manifestations and
arrhythmia.
Results: (1) All 25 patients were successfully implanted ILR, no pocket infection,
bleeding complications. Patients were followed up for 6-47 months (mean
19.311.6). (2) The follow-up period in 25 patients ILR is manual/automatic
recording 709 times, which triggered manually record 45 times (6.3%), ILR trigger
automatically record 664 times (93.7%). (3) In the 542 times ECG recorded:sinus
bradycardia 40 times (7.4%), 51 times room sex is tachycardia (9.4%), atrial ﬂutter 24
times (4.4%), atrial ﬁbrillation 61 times (11.3%), ventricular tachycardia 27 timesardiovascular Disease Clinical Research C165
(5.0%), normal sinus rhythm 208 times (38.4%). Interference wave of 131 times
(24.2%). (4) ILR patients during the follow-up period 17 cases (68%)with symp-
toms,13cases(52%) recorded to meaningful ECG was clear cause. 5 patients were
asymptomatic but records into meaningful ECG was diagnosed. 18 patients(72%) with
cardiac arrhythmias. (5) 18 cases of arrhythmia events recorded in patients by ILR, 2
cases not willing to once again ablation of atrial ﬂutter, 5 cases of atrial tachycardia
and 1 cases ventricular tachycardia in patients with antiarrhythmic drug therapy. 1
cases of before AF ablation with syncope symptom and paroxysmal atrial ﬁbrillation,
syncope again after ablation, ILR recorded syncope cause by ventricular tachycardia.
4 patients in sinus Beckoning bradycardia patients. After ablation of atrial ﬁbrillation
in 4 patients with atrial ﬁbrillation, 1 cases of recurrent AFL patient underwent
radiofrequency ablation. By the ILR, the 4 cases can be used to monitor the burden of
atrial ﬁbrillation in primary ablation: 25.711.4%, 23.97.5%, 19.15.6%,
18.73.2%.
Conclusions: ILR has the advantages of efﬁcient, safe, durable, high intelligence,
information can be stored. Model ILR can be obtained from the burden of atrial
ﬁbrillation, ventricular rate during atrial ﬁbrillation, the diurnal average heart rate,
heart rate variability and trends in activity. It provide objective basis for clinical
judgment, ablation of atrial ﬁbrillation occurred recurrence rate and other cardiac
events, and help for the reasonable application of anticoagulative drugs, help to reduce
the risk of ischemic and hemorrhagic events; anti arrhythmic drugs or radio frequency
ablation again provide reasonable and effective therapy.
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Combining use of Amiodarone and Esmolol In Management of Patients with
Ventricular Electrical Storm
He Yiping, Guo Hangyuan
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Objectives: To analyze the management of ventricular electrical storm with amio-
darone and esmolol.
Methods: We conducted a retrospective analysis during last 5 years in our hospital.
To review and assess the causes, differential diagnosis and treatment with ventricular
electrical storm (VES). VES was deﬁned by 2 or more sustained episodes of ven-
tricular tachycardia or ventricular ﬁbrillation within 24 hours. All patients were treated
with electrical conversion or deﬁbrillation emergently, and treated with amiodarone, if
ineffective esmolol would be used.
Results: A total of 15 cases of ventricular electrical storm (ES) were included. Causes
of ventricular ES included: coronary atherosclerotic heart disease (n¼7), Brugada
syndrome (n¼1), Dilated cardiomyopathy (n¼3), Acute myocarditis (n¼1), Aconitine
poisoning (n¼1), Idiopathic ventricular tachycardia (n¼2). All patients were treated
with electrical conversion or deﬁbrillation emergently with averagely 4.5 times. All
cases were received intravenous injection of amiodarone,5 cases were effective ( the
effective rate was 33%).10 cases were resistant to amiodarone, and 7 cases were
successful managed by intravenous injection of esmolol (the effective rate was 70%).
3 cases were died within 24 hours, 12 cases were treated successfully (the total
effective rate of amiodarone and esmolol was 80%),After the ventricular ES subsided,
3 cases accepted ICD implantation, All 12 cases treated with amiodarone and betaloc
oral maintenance. 1 case died suddenly during a half year follow-up, None of VES
recurrence were monitored among the others.
Conclusions: Combining use of amiodarone and esmolol is effective in management
of patients with ventricular electrical storm, the early use of beta-blocking agent
especially esmolol should be considered.
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Objectives: Atrial ﬁbrillation (AF) is the most frequent arrhythmia seen in clinical
practice. Antiarrhythmic drug (AAD) has a modest long-term efﬁcacy and the po-
tential for serious side effects. Catheter ablation (CA) is now considered as a viable
alternative to AAD in maintaining sinus rhythm in patients with AF. Numerous
systematic reviews (SRs) comparing CA with AAD for AF have already been pub-
lished. Then, it is necessary and important to summarise the results of these SRs in an
overview. To conduct an overview of SRs that evaluates the efﬁcacy and safety of CA
comparing with AAD for patients with AF.
Methods: We searched the Cochrane Library, PubMed, EMBASE, Web of Science
and Chinese databases (CBM, CNKI and Wanfang) electronically and also retrieved
papers from other sources, such as searching the reference lists of all included reviews
and carrying out a citation search of those papers which cited studies included in the
review. All relevant SRs were collected to compare CA with AAD for the mainte-
nance of sinus rhythm in patients with AF. There were no language restrictions, and
we did not restrict inclusion by the kinds of CA or AAD. Two investigators inde-
pendently screened studies, extracted data and assessed the methodological quality
according to appropriate criteria. Then all of these results were checked by a third
investigator. We conducted this overview of SRs by descriptive analysis.
Results: We identiﬁed seventeen SRs for inclusion within this overview altogether,
including one Cochrane reviews and sixteen non-Cochrane reviews. One paper was
published in Chinese and the others in English. Most of the included SRs have eligibleC166 JACC Vol 64/16/Suppl C j October 16–1methodological quality. A non-Cochrane systematic review showed similar survival of
patients with AF undergoing CA compared with AAD after 12 months of follow-up,
and with no difference in the rates of stroke or transient ischemic attack. Synthesized
results of other sixteen SRs demonstrated that CA is superior to AAD for patients with
paroxysmal or persistent AF, which was associated with higher efﬁcacy rates and a
lower rate of serious complications. Additionally, three SRs performed the economic
evaluation compared between CA and AAD, and the synthesized analysis indicated
that compared to the AAD strategy, CA had a higher costs with better effectiveness.
Conclusions: Evidence from the present SRs suggest that CA may be a better treat-
ment option compared to AAD in the management of AF. We can consider CA as a
relatively effective and well-tolerated procedure for maintaining sinus rhythm.
However, the comparison of long-term efﬁcacy and safety between CA and AAD, as
well as economic variable, should be further evaluated by more large sample and high
quality studies. Ongoing clinical trials in the future may provide further information
for guidance on these treatment options for AF.
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Radiofrequency catheter ablation Of right atrioventricular accessory pathway
via unconventional left subclavian veinous access
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Objectives: To prove the effectiveness of radiofrequency catheter ablation (RFCA) of
right atrioventricular accessory pathway Via Left subclavian veinous Access.
Methods: 22 patients [14 men average age of (41.23.7) years old] underwent
conventional electrophysiological study and diagnostic Right Atrioventricular acces-
sory pathway, but unsuccessfully RFCA via femoral vein access. Try to RFCA via
unconventional left subclavian veinous access.
Results: The right atrioventricular accessory pathway were successfully eliminated by
RFCA in all 22 cases during operation. The sites of the accessory pathway were from
the right anterior septum in 3, the right free wall in 11, the right posterolater in 8 cases.
After ablation, no patient had recurrence. The success rate was 100%.
Conclusions: The anatomy of right atrioventricular accessory pathway is compara-
tively special. Occasionally, it is difﬁcult to RFCA via femoral vein access. It’s
suggested that RFCA of right atrioventricular accessory pathway by unconventional
left subclavian veinous access may be an alternative approach.
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Variation and signiﬁcance of serum CARP, hs-CRP in patients with atrial
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Objectives: To explore the changes of serum levels of CARP, hs-CRP in patients with
atrial ﬁbrillation and its signiﬁcance, and survey the relationship among CARP, hs-
CRP and cardiac function.
Methods: 124 patients of our department were divided into atrial ﬁbrillation group
(n¼64) and sinusrhythm group (n¼60) according to ECG. The two groups were
divided into three subgroups (the NYHA class I, the NYHA class II and the NYHA
class III) according to the NYHA cardiac function class. On the second morning,
Serum CARP levels in all patients were measured by enzyme-linked immune sorbent
assay (ELISA), and serum hs-CRP levels were measured by latex enhance immune
and turbidimetric immunoassay (PETIA).Then the levels of them were dealed with
statistical analysis.
Results: (1) The levels of serum CARP, hs-CRP in atrial ﬁbrillation group were
signiﬁcantly higher than those in sinus rhythm group (P<0.05).In the same NYHA
class subgroup, the levels of serum CARP, hs-CRP in atrial ﬁbrillation group were
signiﬁcantly higher than those in sinus rhythm group (P<0.05). (2) The levels of
serum CARP, hs-CRP both in atrial ﬁbrillation group and in sinus rhythm group were
in sequence increased signiﬁcantly with the NYHA class (P<0.05).
Conclusions: (1) The levels of serum CARP, hsCRP in atrial ﬁbrillation group were
signiﬁcantly higher than those in sinus rhythm group. The levels of serum CARP and
hsCRP were signiﬁcantly increased with the deterioration of cardiac function. (2)
CARP and hsCRP may be involved in the occurrence and sustainment of atrial
ﬁbrillation. The levels of serum CARP, hsCRP may serve as an independent index of
atrial ﬁbrillation.
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Efﬁcacy of adjunctive ablation of complex fractionated atrial electrograms and
pulmonary vein isolation in patients with atrial ﬁbrillation: a meta-analysis
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Objectives: To compare the efﬁcacy and safety of pulmonary vein isolation (PVI)
versus PVI plus adjunctive ablation of complex fractionated atrial electrograms
(CFAEs) in patients with atrial ﬁbrillation (AF) after a single procedure.
Methods: Literature search was conducted in PubMed, EMBASE, Cochrane Library,
CBM, Elsevier, CNKI and VIP for the clinical controlled trials of PVI versus PVI plus
adjunctive ablation of CFAEs in patients with AF, from January 1, 1980 to August 31,9, 2014 j GW-ICC Abstracts/Cardiovascular Disease Clinical Research
